PubRank

J R Paterniti

Author PubWeight™ 34.27‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Nature 1997 2.12
2 Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor. Proc Natl Acad Sci U S A 2001 1.74
3 Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARgamma2 versus PPARgamma1 and activation with retinoid X receptor agonists and antagonists. J Biol Chem 1997 1.56
4 Combined lipase deficiency (cld): a lethal mutation on chromosome 17 of the mouse. Science 1983 1.44
5 Lipoprotein metabolism during acute inhibition of hepatic triglyceride lipase in the cynomolgus monkey. J Clin Invest 1982 1.39
6 Effects of PYY[3-36] in rodent models of diabetes and obesity. Int J Obes Relat Metab Disord 2004 1.19
7 Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne. N Engl J Med 1985 1.15
8 A selective peroxisome proliferator-activated receptor-gamma (PPARgamma) modulator blocks adipocyte differentiation but stimulates glucose uptake in 3T3-L1 adipocytes. Mol Endocrinol 2000 1.11
9 Skeletal muscle peroxisome proliferator- activated receptor-gamma expression in obesity and non- insulin-dependent diabetes mellitus. J Clin Invest 1998 1.02
10 Peroxisome proliferator-activated receptor (PPAR) gamma and retinoid X receptor (RXR) agonists have complementary effects on glucose and lipid metabolism in human skeletal muscle. Diabetologia 2001 1.00
11 Regulation of lipoprotein metabolism by thiazolidinediones occurs through a distinct but complementary mechanism relative to fibrates. Arterioscler Thromb Vasc Biol 1997 0.96
12 Combined lipase deficiency (cld/cld) in mice. Demonstration that an inactive form of lipoprotein lipase is synthesized. J Biol Chem 1985 0.92
13 Metabolism of apoprotein B in cynomolgus monkey: evidence for independent production of low-density lipoprotein apoprotein B. Am J Physiol 1983 0.90
14 RXR agonists activate PPARalpha-inducible genes, lower triglycerides, and raise HDL levels in vivo. Arterioscler Thromb Vasc Biol 1998 0.90
15 High level expression of human apolipoprotein A-I in transgenic rats raises total serum high density lipoprotein cholesterol and lowers rat apolipoprotein A-I. Transgenic Res 1992 0.89
16 Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase. J Clin Invest 1985 0.88
17 Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight. Int J Obes (Lond) 2009 0.88
18 Production and use of an inhibitory monoclonal antibody to human lipoprotein lipase. Biochim Biophys Acta 1986 0.87
19 Plasma lipolytic activity. Relationship to postheparin lipolytic activity and evidence for metabolic regulation. Diabetes 1988 0.84
20 Membrane-bound lipoprotein lipase on human monocyte-derived macrophages: localization by immunocolloidal gold technique. Biochim Biophys Acta 1988 0.84
21 delta-Aminolevulinic acid synthetase from rat liver mitochondria. Purification and properties. J Biol Chem 1979 0.83
22 Plasma lipoprotein abnormalities associated with acquired hepatic triglyceride lipase deficiency. Metabolism 1985 0.83
23 Peroxisome proliferator-activated receptor subtype-specific regulation of hepatic and peripheral gene expression in the Zucker diabetic fatty rat. Metabolism 2001 0.83
24 Effect of the combined lipase deficiency mutation (cld/cld) on ultrastructure of tissues in mice. Diaphragm, heart, brown adipose tissue, lung, and liver. Lab Invest 1986 0.82
25 Detection and regulation of delta-aminolevulinic acid synthetase activity in the rat brain. Arch Biochem Biophys 1978 0.81
26 Interaction of lipoprotein lipase with heparin. Ann N Y Acad Sci 1989 0.80
27 Nonimmunochemical quantitation of mammalian apolipoprotein A-I in whole serum or plasma by nonreducing gel electrophoresis. J Lipid Res 1989 0.80
28 delta-Aminolevulinic acid synthetase: regulation of activity in various tissues of the aging rat. Arch Biochem Biophys 1978 0.78
29 Overexpression of human apolipoprotein A-I in transgenic rats and the hyperlipoproteinemia associated with experimental nephrosis. J Lipid Res 1995 0.78
30 Regulation of heme metabolism during senescence: activity of several heme-containing enzymes and heme oxygenase in the liver and kidney of aging rats. Mech Ageing Dev 1980 0.78
31 Design and synthesis of 2-methyl-2-[4-(2-[5-methyl-2-aryloxazol-4-yl]ethoxy)phenoxy]propionic acids: a new class of dual PPARalpha/gamma agonists. J Med Chem 2001 0.77
32 Measurement of lipoprotein lipase and hepatic triacylglycerol lipase in post-heparin plasma of the cynomolgus monkey. Biochim Biophys Acta 1983 0.77
33 Effect of experimental nephrosis on hepatic lipoprotein secretion and urinary lipoprotein excretion in rats expressing the human apolipoprotein A-I gene. J Lipid Res 1996 0.77
34 Expression of lipoprotein lipase gene in combined lipase deficiency. Biochim Biophys Acta 1989 0.76
35 Accumulation of cholestatic lipoproteins in ANIT-treated human apolipoprotein A-I transgenic rats is diminished through dose-dependent apolipoprotein A-I activation of LCAT. Biochim Biophys Acta 2000 0.76
36 Selective inhibition of growth by the proline analogue thiazolidine-4-carboxylic acid and its probable mode of action in Saccharomyces cerevisiae. Antimicrob Agents Chemother 1975 0.75
37 Metabolic interrelationships during aging: the heme metabolic pathways. Mt Sinai J Med 1980 0.75
38 Very low-density lipoprotein metabolism in an unusual case of lipoatrophic diabetes. Metabolism 1984 0.75
39 Transient lipoprotein lipase deficiency with hyperchylomicronemia. Am J Med Sci 1983 0.75
40 Measurement of heparin-releasable triacylglycerol lipases. Lab Res Methods Biol Med 1984 0.75